← Back to Search

Behavioural Intervention

Enhanced Telemedicine for Type 2 Diabetes

N/A

Waitlist Available

Led By Margaret Zupa, MDMS

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of type 2 diabetes based on abbreviated ICD-10 code E11.X in medical record or self-report

Patient must use multiple daily injections of insulin

Must not have

Age over 80 based on date of birth in electronic medical record

Dementia based on abbreviated ICD-10 codes

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if providing high-quality diabetes care through telemedicine is feasible for adults with type 2 diabetes who use insulin and have multiple chronic health conditions. They want to know if this enhanced

Who is the study for?

This trial is for adults with type 2 diabetes who use insulin and have multiple chronic conditions. Participants will engage in telemedicine visits over about 6 months. They must be willing to complete surveys during their care visits.

What is being tested?

The study compares usual telemedicine endocrinology care with an enhanced version for managing type 2 diabetes. The enhanced program includes pre-visit calls, education, support, and post-visit follow-ups to see if it improves patient satisfaction or clinical outcomes.

What are the potential side effects?

Since this trial focuses on telemedicine services rather than medication or invasive procedures, traditional side effects are not a concern here. However, participants may experience issues related to the technology used or dissatisfaction with remote communication.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with type 2 diabetes.

Select...

I use insulin injections several times a day.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am over 80 years old.

Select...

I have been diagnosed with dementia.

Select...

I have a cancer diagnosis other than non-melanoma skin cancer.

Select...

I have been diagnosed with diabetes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Loss to follow up

Recruitment percentage

Secondary study objectives

Blood glucose data availability

Diabetes Treatment Satisfaction Questionnaire-change version

Diabetes Treatment Satisfaction Questionnaire-static version

+13 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Enhanced Telemedicine CareExperimental Treatment1 Intervention

Specialty care for type 2 diabetes delivered via telemedicine by an endocrinologist, with additional multidisciplinary support from the diabetes care team.

Group II: Usual CareActive Control1 Intervention

Specialty care for type 2 diabetes delivered via telemedicine by an endocrinologist following usual clinical care protocols.

0 / 6Eligibility criteria met